Esperion Therapeutics, Inc (ESPR) Covered Calls

Esperion Therapeutics, Inc covered calls Esperion Therapeutics Inc is engaged in the research, development and commercialization of therapies for the treatment of patients with elevated levels of elevated levels of LDL-C.

You can sell covered calls on Esperion Therapeutics, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ESPR (prices last updated Fri 4:16 PM ET):

Esperion Therapeutics, Inc (ESPR) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
51.73 +0.76 51.66 54.23 503K -6.5 1.4B
Covered Calls For Esperion Therapeutics, Inc (ESPR)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Jun 21 50 3.80 50.43 -0.9% -9.1%
Sep 20 50 6.70 47.53 5.2% 14.9%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Esperion Therapeutics, Inc. is a clinical stage biopharmaceutical company, which focuses on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol lowering therapies for the treatment of patients with hypercholesterolemia and other cardiometabolic risk markers. The company's products include ETC-1002. Esperion Therapeutics was founded by Roger S. Newton in January 2008 and is headquartered in Ann Arbor, MI.